A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Seeka lifts earnings guidance again
Primary Sector

Seeka lifts earnings guidance again

Seeka has once again lifted its market guidance off the back of a “strong close out” to its 2024 year.The New Zealand Exchange-listed (NZX) horticulture business now expects full-year earnings at a profit before tax level for the year ended Dec 31 to be between $27.5 million and...

Riley Kennedy 21 Jan 2025
The business and science alliance turning waste into profits
Primary Sector

The business and science alliance turning waste into profits

Many NZ companies don't have the time or resources to carry out R&D inhouse.

Greg Hurrell 21 Jan 2025
Fonterra's ingredients chief on second Trump presidency
Primary Sector

Fonterra's ingredients chief on second Trump presidency

The incoming US President has threatened tariffs on all imports. 

Riley Kennedy 21 Jan 2025